GR-MD-02 + Pembrolizumab Versus Pembrolizumab Monotherapy in Melanoma and Squamous Cell Head and Neck Cancer Patients

Clinical trial NCT04987996 · WITHDRAWN

Trial details

NCT number: NCT04987996
Sponsor: Providence Health & Services
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Melanoma Head and Neck Squamous Cell Carcinoma

Start date: 2023-07-01
Primary completion: 2027-07-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.